OPTOMED Optomed Oyj

1.812USD1.652 EUR · HEL-2.82%Mkt Cap: 38.83M USDP/E: —

Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufa…

Key Statistics

Company
Market Cap38.83M USD
Enterprise Value33.84M USD
Revenue (TTM)18.50M USD
Gross Profit11.93M USD
Net Income (TTM)-7.28M USD
Revenue/Share0.88 USD
Last Price1.812 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees103
CountryFI
SectorHealthcare
IndustryHealth Information Services
ISINFI4000410881
Valuation
P/E (Trailing)—
P/E (Forward)-18.36
PEG—
EV/EBITDA-9.58
EV/Revenue1.83
P/S2.10
P/B1.59
EPS (TTM)-0.19 USD
EPS (Forward)-0.10 USD
52W Range
1.45011% of range4.716
52W High4.716 USD
52W Low1.450 USD
Profitability
Gross Margin63.61%
Oper. Margin-24.36%
EBITDA Margin-19.09%
Profit Margin-38.84%
ROE-27.65%
ROA-20.77%
ROIC-35.51%
ROCE-23.80%
Growth
Revenue Growth17.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.72M USD
CapEx (TTM)2.59M USD
FCF Margin-7.46%
FCF Yield-3.56%
Net Debt-5.07M USD
Net Debt/EBITDA1.43
Net Debt/FCF—
Balance Sheet
Debt/Equity0.11
Current Ratio2.33
Quick Ratio1.85
Book Value/Sh1.14 USD
Cash/Share0.36 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.5 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.486 USD
Upside (mean)+37.2%
Target Range1.974 USD – 3.290 USD
1.974+37.2% to mean3.290
# Analysts3
Ownership
Shares Out.21.43M
Float20.88M
Insiders5.63%
Institutions28.21%
Technical
SMA 501.657 (+9.3%)
SMA 2002.064 (-12.2%)
Beta1.59
S&P 52W Chg12.00%
Avg Vol (30d)59.27K
Avg Vol (10d)120.44K
Technical Indicators
RSI (14)55.3
MACD0.0704
MACD Signal0.0569
MACD Hist.+0.0135
BB Upper2.059 USD
BB Middle1.722 USD
BB Lower1.384 USD
BB Width39.22%
ATR (14)0.1019 USD
Vol Ratio (20d)0.73x

About Optomed (HEL: OPTOMED)

›

Optomed (HEL: OPTOMED) is listed on Nasdaq Helsinki, where its shares trade in EUR. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 103 employees.

The shares were at 1.652 EUR on 19 November 2026, down 60.0% over 52 weeks. Its 52-week range is 1.322 EUR to 4.300 EUR: the price is 61.6% below the high and 25.0% above the low.

Its market capitalisation is 35.40M EUR.

Optomed reports return on equity of -27.6%, an operating margin of -24.4% and revenue up 17.5% year over year.

It holds more cash than debt, a net cash position of 4.62M EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 3 analysts cover the stock, with an average rating of Hold; their mean price target of 2.267 EUR is 37.2% above the current price. The next earnings report is expected on 18 February 2027.